S3721 Prostate cancer antigen 3 (pca3) testing

Short descriptor: Pca3 testing

⚠ Terminated HCPCS Level II 2026
Terminated Code
S3721 was terminated as of 2015-12-31 and should not be reported for dates of service after that date. This page is retained for historical reference.
Open S3721 in the app →

Look up S3721 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

S3721 is the HCPCS Level II code for Prostate cancer antigen 3 (pca3) testing (2026). It belongs to Section S — Temporary National Codes (Non-Medicare). Under Medicare, its coverage status is: Not payable by Medicare. Part B pricing methodology: Not separately priced by Part B.

Classification & CMS Attributes

Medicare Coverage
Not payable by Medicare (code I)
Part B Pricing
Not separately priced by Part B (indicator 00)
Type of Service
Other medical items or services
Effective Date
2016-01-01
Termination Date
2015-12-31
2026 Maintenance
No change this year

References

Cite This Page

Reference S3721 with the canonical source and edition:

S3721 — Prostate cancer antigen 3 (pca3) testing. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/S3721

Canonical URL: https://icd10codingpro.com/hcpcs-codes/S3721

Related Codes in Section S

Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial